SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-007146
Filing Date
2018-11-08
Accepted
2018-11-08 16:59:16
Documents
6
Period of Report
2018-12-07
Effectiveness Date
2018-11-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2236994zdef14a.htm DEF 14A 605158
2 G807341.JPG g807341.jpg GRAPHIC 2213
3 G875589.JPG g875589.jpg GRAPHIC 9294
4 G599344.JPG g599344.jpg GRAPHIC 2204
5 G810808.JPG g810808.jpg GRAPHIC 2514
6 G858129.JPG g858129.jpg GRAPHIC 2190
  Complete submission text file 0001047469-18-007146.txt   632335
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37686 | Film No.: 181170429
SIC: 2834 Pharmaceutical Preparations